3-(3-Chlorophenyl)-4-((4-(dimethylamino)benzylidene)amino)-1H-1,2,4-triazole-5(4H)-thione

Catalog No. :
ACRTCT047
CAS No. :
478255-02-6
Molecular Formula :
C17H16ClN5S
Molecular Weight :
357.87

IUPAC Name:(E)-5-(3-chlorophenyl)-4-((4-(dimethylamino)benzylidene)amino)-2,4-dihydro-3H-1,2,4-triazole-3-thione

3-(3-Chlorophenyl)-4-((4-(dimethylamino)benzylidene)amino)-1H-1,2,4-triazole-5(4H)-thione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(3-Chlorophenyl)-4-((4-(dimethylamino)benzylidene)amino)-1H-1,2,4-triazole-5(4H)-thione
IUPAC Name(E)-5-(3-chlorophenyl)-4-((4-(dimethylamino)benzylidene)amino)-2,4-dihydro-3H-1,2,4-triazole-3-thione
MDL No.MFCD03675687
Molecular FormulaC17H16ClN5S
Molecular Weight357.87
SMILESS=C1NN=C(C2=CC=CC(Cl)=C2)N1/N=C/C3=CC=C(N(C)C)C=C3
InChI KeyVLTAXXKEMIVQDN-YBFXNURJSA-N
SynonymSALOR-INT L229725-1EA;5-(3-CL-PH)-4-((4-(DIMETHYLAMINO)BENZYLIDENE)AMINO)-4H-1,2,4-TRIAZOLE-3-THIOL;3-(3-chlorophenyl)-4-[(E)-[4-(dimethylamino)phenyl]methylideneamino]-1H-1,2,4-triazole-5-thione;3H-1,2,4-Triazole-3-thione, 5-(3-chlorophenyl)-4-[[[4-(dimethylamino)phenyl]methylene]amino]-2,4-dihydro-
CAS No.478255-02-6

Synthetic Route by SureRoute

1. ACRTCT047 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBNPV839 route compound structure diagram
    ACBNPV839100-10-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRTCT047 route product structure diagram
    ACRTCT047478255-02-6
Inquiry

2. ACRTCT047 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRTCT047 route product structure diagram
    ACRTCT047478255-02-6
Inquiry

Comments (0)